Where does PCI Biotech AS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), PCI Biotech AS ranks #23,172 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does PCI Biotech AS hold?

PCI Biotech AS holds 12 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is PCI Biotech AS's Innovation Score?

PCI Biotech AS has an Innovation Score of 34.9 out of 100 (top 51% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does PCI Biotech AS focus on?

PCI Biotech AS's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 12 patents. Grants appear in 11 CPC subclasses total.

Is PCI Biotech AS's patent grant rate increasing or decreasing?

PCI Biotech AS's recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for PCI Biotech AS's patents?

PCI Biotech AS's patents average 21.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the PCI Biotech AS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

PCI Biotech AS

USPTO PatentsView assignee record - 12 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, PCI ranks #23,172 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 11 technology areas.

#23,172
of 50,000 US assignees by volume: Top 51%
by Innovation Score (34.9/100): 21.7
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23172 · Foreign Corporation #23,172 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,172/50,000
PHOTO-FINISH Oxford BioTherapeutics
CPC-FOCUS A61K · 11 areas
INNOV-THIN 34.9/100
CLAIMS-DENSE 21.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oxford Biotherapeutics Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
PCI Biotech AS · this assignee

35
3D Lighting Innovati… · lowest

7

What this shows PCI's Innovation Score is 34.9/100 (top 51% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where PCI's grants concentrate

PCI Biotech AS is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2015. By volume, PCI sits between Oxford Biotherapeutics Ltd and Peninsula Packaging, Llc.

Oxford Biotherape…

12
Pablo AIR Interna…

12
Paneratech

12
PARI Spezialisten…

12
PDS Biotechnology

12
Pellerin Milnor

12
Pellion

12
Peninsula Packagi…

12
PCI Biotech AS ◀

12

What this shows PCI holds 12 patents at rank #23,155, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near PCI

By rank, the assignees closest to #23,155 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in PCI's primary technology class.

PCI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 51% higher than 49% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

PCI Biotech AS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2016	1	8.3%
2017	2	16.7%
2018	1	8.3%
2019	1	8.3%
2020	2	16.7%
2021	2	16.7%
2023	1	8.3%
2025partial year	1	8.3%

Which technologies does PCI Biotech AS patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 12

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 10

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 4

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 4

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 1

C08B - POLYSACCHARIDES; DERIVATIVES THEREOF 1

C07K - PEPTIDES 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#23,172

of 50,000 tracked assignees

Innovation Score

34.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.